EUVIMEDScopri EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances

Magdalena I Ivanova iD, Carmelo La Rosa, Ayyalusamy Ramamoorthy

Protein Science · 2026-04 · 35 (4)

DOI: 10.1002/pro.70525 ↗

At a glance

Übersichtsarbeit in Protein Science, published online on 2026-03-12. Written by Magdalena I Ivanova and 2 co-authors. Institution: Biophysics Program, University of Michigan, Ann Arbor, Michigan, USA. Major MEDLINE topics: Amyloid, Amyloidogenic Proteins. Cited 11 times so far (Crossref); 299 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIH HHS, National Science Foundation, State of Florida.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Oligomeric assemblies of amyloidogenic proteins, such as Aβ, tau, α‐synuclein, amylin, transthyretin, and TDP‐43, are increasingly recognized as key drivers of cellular dysfunction across a range of neurodegenerative and systemic disorders. However, their molecular properties remain poorly understood due to their low abundance, structural heterogeneity, and transient nature. This review outlines current methods for studying amyloid oligomers, including biophysical (NMR, cryo‐EM, HS‐AFM, mass spectrometry), computational (molecular dynamics simulations), and biological (cellular assays, organoids, and animal models) approaches. This review also covers emerging methods for detecting misfolded proteins within complex biological environments and live‐cell systems. Furthermore, we discuss recent advances that specifically address the challenges of studying oligomers, which are yielding crucial data on how these pathogenic species impair cellular homeostasis. Given the heterogeneity and transient nature of the oligomers, it is essential to utilize findings across diverse experimental platforms that yield complementary data and apply methods that also ensure reproducibility and mechanistic clarity with the goal of translating these findings into effective therapeutic strategies.

Subjects

MeSH terms (MEDLINE)

AmyloidAmyloidogenic ProteinsHumansAnimalsProtein Folding

Author keywords

amyloidbiophysical methodscellular modelsdiseaseoligomerspolymorphismprotein aggregationprotein misfoldingstructure

Substances

AmyloidAmyloidogenic Proteins

Authors and institutions

  • Biophysics Program, University of Michigan, Ann Arbor, Michigan, USA.
  • Michigan Neuroscience Institute, University of Michigan, Ann Arbor, Michigan, USA.
  • Dipartimento di Scienze Chimiche, Università degli Studi di Catania, Catania, Italy.
  • Department of Chemical and Biomedical Engineering, FAMU-FSU College of Engineering, Florida State University, Tallahassee, Florida, USA.
  • National High Magnetic Field Laboratory, Tallahassee, Florida, USA.
  • Institute Molecular Biophysics, Florida State University, Tallahassee, Florida, USA.

ORCID profiles: Magdalena I Ivanova

Funding

  • NIH HHS
  • National Science Foundation
  • State of Florida
  • National Institutes of Health

Cite

APA

Ivanova, M. I., La Rosa, C., & Ramamoorthy, A. (2026). In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances. Protein Science, 35(4). https://doi.org/10.1002/pro.70525

Vancouver

Ivanova MI, La Rosa C, Ramamoorthy A. In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances. Protein Science. 2026;35(4). doi:10.1002/pro.70525

BibTeX
@article{Ivanova2026,
  author = {Ivanova, Magdalena I and La Rosa, Carmelo and Ramamoorthy, Ayyalusamy},
  title = {In vitro, cellular and in vivo studies of amyloid oligomers structure and toxicity: Challenges and advances},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {4},
  doi = {10.1002/pro.70525}
}
Start for free →